NEWER 5-AMINOSALICYLIC ACID BASED DRUGS IN CHRONIC INFLAMMATORY BOWEL-DISEASE

被引：0
|
作者：
JARNEROT, G
机构：
来源：
DRUGS | 1989年 / 37卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：73 / 86
页数：14
相关论文
共 50 条
  • [41] Role of 5-aminosalicylic acid (5-ASA) in treatment of inflammatory bowel disease -: A systematic review
    Gisbert, JP
    Gomollón, F
    Maté, J
    Pajares, JM
    DIGESTIVE DISEASES AND SCIENCES, 2002, 47 (03) : 471 - 488
  • [42] Impact of concomitant 5-aminosalicylic acid therapy on vedolizumab efficacy and safety in Inflammatory Bowel Disease
    Ungaro, R.
    Kadali, H.
    Zhang, W.
    Adsul, S.
    Reinisch, W.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S321 - S321
  • [43] 5-aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease
    Terdiman, Jonathan P.
    Steinbuch, Michael
    Blumentals, William A.
    Ullman, Thomas A.
    Rubin, David T.
    INFLAMMATORY BOWEL DISEASES, 2007, 13 (04) : 367 - 371
  • [44] Lupus-like syndrome caused by 5-aminosalicylic acid in patients with inflammatory bowel disease
    Kirkpatrick, AW
    Bookman, AA
    Habal, F
    CANADIAN JOURNAL OF GASTROENTEROLOGY, 1999, 13 (02): : 159 - 162
  • [45] Impact of 5-Aminosalicylic Acid on Ustekinumab in Inflammatory Bowel Disease: A Retrospective Medical Claims Analysis
    Nishida, Yu
    Hosomi, Shuhei
    Fujimoto, Koji
    Kobayashi, Yumie
    Nakata, Rieko
    Maruyama, Hirotsugu
    Ominami, Masaki
    Nadatani, Yuji
    Fukunaga, Shusei
    Otani, Koji
    Tanaka, Fumio
    Fujiwara, Yasuhiro
    INFLAMMATORY BOWEL DISEASES, 2025,
  • [46] Synthesis, characterization and evaluation of derivates of 5-aminosalicylic acid with antioxidant activity in inflammatory bowel disease
    Ramirez Duran, Leticia Araceli
    Trujillo Ferrara, Jose Guadalupe
    Cecilia Rosales-Hernandez, Martha
    Ramirez Rosales, Daniel
    Correa Basurto, Jose
    FASEB JOURNAL, 2010, 24
  • [47] A NEW SLOW-RELEASE FORM OF 5-AMINOSALICYLIC ACID FOR THE ORAL TREATMENT OF INFLAMMATORY BOWEL-DISEASE - BIOPHARMACEUTIC AND CLINICAL PHARMACOKINETIC CHARACTERISTICS
    KLOTZ, U
    MAIER, KE
    FISCHER, C
    BAUER, KH
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1985, 35-1 (03): : 636 - 639
  • [48] 5-AMINOSALICYLIC ACID - A NEW THERAPEUTIC APPROACH TO CHRONIC INFLAMMATORY DISEASES OF THE SMALL-BOWEL - REPLY
    HARTMANN, F
    LEBER MAGEN DARM, 1986, 16 (03) : 177 - 178
  • [49] THE TREATMENT OF CHRONIC INFLAMMATORY INTESTINAL-DISEASES WITH 5-AMINOSALICYLIC ACID
    MALCHOW, H
    INTERNIST, 1987, 28 (01): : 14 - 20
  • [50] Synthesis and activity of novel 5-aminosalicylic acid (5-ASA)-containing pro-drugs for the treatment of inflammatory bowel disease (IBD).
    Riggs-Sauthier, JA
    Malson, E
    Harris, M
    Myung, S
    Liddle, R
    Ekwuribe, N
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U60 - U60
12345